Tuberculosis Testing Device
Request Info
The TB Breathalyser from Rapid Biosensor Systems Ltd. is a testing device for active infectious tuberculosis, delivering results two minutes after sample collection.
The disposable Breathalyser technology was proven in field trials with high sensitivity and specificity of 95 percent. The small, robust and simple to use test is noninvasive and cost-effective in operation.
The company’s patent-protected system is based on scalable, low-cost photonics componentry, making the product highly competitive for tuberculosis screening in emerging market economies.
The TB Breathalyser received a 2017 Prism Award, sponsored by SPIE and Photonics Media, at Photonics West 2017 in San Francisco.
http://www.rapidbiosensor.com
BioPhotonics
May/Jun 2017